Tracks safety and effectiveness of Medtronic products on the market
Follows people treated with Medtronic devices for heart rhythm, brain, bladder and digestive conditions.
Plain-language title generated from the registry record
Registry title: Product Surveillance Registry
Key facts
- Where
- Calgary, Kingston, Montreal, Québec, and Toronto, CanadaSee the 5 sites
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people who have, or are about to receive, a Medtronic product that is already on the market, to follow its safety and performance.
- Sex
- All sexes can join.
- Earlier treatment
- The person has been treated with, or is going to be treated with, a Medtronic product that is allowed in this registry. They must be within the enrollment window around the start of therapy, or meet the rules for joining later.
Main reasons for not taking part
- People who cannot be reached for follow-up
- People who meet exclusion rules set by local law
- People already in, or planning to join, another drug or device study that could affect the results
Read by machine on 12 November 2026.
Where in Canada
- Calgary, AlbertaHospital not named in the registryContact: Medtronic Product Surveillance RegistryTaking people
- Kingston, OntarioHospital not named in the registryContact: Medtronic Product Surveillance RegistryTaking people
- Montreal, QuebecHospital not named in the registryContact: Medtronic Product Surveillance RegistryTaking people
- Québec, QuebecHospital not named in the registryContact: Medtronic Product Surveillance RegistryTaking people
- Toronto, OntarioHospital not named in the registryContact: Medtronic Product Surveillance RegistryTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Medtronic
- Trial code
- NCT01524276
- Record updated
- 20 October 2026
- Original description
The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by streamlining the clinical surveillance process and facilitating leading edge performance assessment via the least burdensome approach.Read full original descriptionShow less
Medtronic Product Surveillance Registry
The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by streamlining the clinical surveillance process and facilitating leading edge performance assessment via the least burdensome approach.
Inclusion: Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements; Patient has or is intended to receive or be treated with an eligible Medtronic product; Patient within enrollment window relative to therapy initiation or meets criteria for retrospective enrollment.
Exclusion: Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results; Patient who is, or will be, inaccessible for follow-up; Patient with exclusion criteria required by local law.